Literature DB >> 31633237

Imaging diamagnetic susceptibility of collagen in hepatic fibrosis using susceptibility tensor imaging.

Hongjiang Wei1,2, Kyle Decker3, Hien Nguyen4, Steven Cao2, Tsung-Yuan Tsai5, Cynthia Dianne Guy4, Mustafa Bashir6,7,8, Chunlei Liu2,9.   

Abstract

PURPOSE: To characterize the magnetic susceptibility changes of liver fibrosis using susceptibility tensor imaging.
METHODS: Liver biopsy tissue samples of patients with liver fibrosis were obtained. Three-dimensional gradient-echo and diffusion-weighted images were acquired at 9.4 T. Susceptibility tensors of the samples were calculated using the gradient-echo phase signal acquired at 12 different orientations relative to the B0 field. Susceptibility anisotropy of the liver collagen fibers was quantified and compared with diffusion anisotropy, measured by DTI. For validation, a comparison was made to histology including hematoxylin and eosin staining, iron staining, and Masson's trichrome staining.
RESULTS: Areas with strong diamagnetic susceptibility were observed in the tissue samples forming fibrous patterns. This diamagnetic susceptibility was highly anisotropic. Both the mean magnetic susceptibility and susceptibility anisotropy of collagen fibers exhibited a strong contrast against the surrounding nonfibrotic tissues. The same regions also showed an elevated diffusion anisotropy but with much lower tissue contrast. Masson's trichrome staining identified concentrated collagens in the fibrous regions with high susceptibility anisotropy, and a linear correlation was found between the susceptibility anisotropy and the histology-based staging.
CONCLUSION: Diamagnetic susceptibility indicates the presence of collagen in the fibrotic liver tissues. Mapping magnetic susceptibility anisotropy may serve as a potential marker to quantify collagen fiber changes in patients with liver fibrosis.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  liver cirrhosis; liver fibrosis; magnetic susceptibility anisotropy; quantitative susceptibility mapping; susceptibility tensor imaging

Mesh:

Substances:

Year:  2019        PMID: 31633237     DOI: 10.1002/mrm.27995

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  5 in total

1.  Integrated quantitative susceptibility and R2 * mapping for evaluation of liver fibrosis: An ex vivo feasibility study.

Authors:  Ramin Jafari; Stefanie J Hectors; Anne K Koehne de González; Pascal Spincemaille; Martin R Prince; Gary M Brittenham; Yi Wang
Journal:  NMR Biomed       Date:  2020-09-22       Impact factor: 4.044

2.  Magnetic resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study.

Authors:  Zheng Qu; Shuohui Yang; Feng Xing; Rui Tong; Chenyao Yang; Rongfang Guo; Jiling Huang; Fang Lu; Caixia Fu; Xu Yan; Stefanie Hectors; Kelly Gillen; Yi Wang; Chenghai Liu; Songhua Zhan; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

3.  Asymmetric susceptibility tensor imaging.

Authors:  Steven Cao; Hongjiang Wei; Jingjia Chen; Chunlei Liu
Journal:  Magn Reson Med       Date:  2021-05-20       Impact factor: 4.668

4.  Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data.

Authors:  Jingjia Chen; Nan-Jie Gong; Khallil Taverna Chaim; Maria Concepción García Otaduy; Chunlei Liu
Journal:  Neuroimage       Date:  2021-08-14       Impact factor: 6.556

Review 5.  Multiparametric MR mapping in clinical decision-making for diffuse liver disease.

Authors:  Helena B Thomaides-Brears; Rita Lepe; Rajarshi Banerjee; Carlos Duncker
Journal:  Abdom Radiol (NY)       Date:  2020-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.